ZNF20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.063790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.145200E-01
Normal-vs-Stage2
1.058790E-01
Normal-vs-Stage3
7.140100E-02
Normal-vs-Stage4
2.655200E-01
Stage1-vs-Stage2
3.053200E-01
Stage1-vs-Stage3
1.903960E-01
Stage1-vs-Stage4
7.392200E-01
Stage2-vs-Stage3
3.930400E-01
Stage2-vs-Stage4
6.573600E-01
Stage3-vs-Stage4
3.387000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.677500E-02
Normal-vs-AfricanAmerican
3.099600E-02
Normal-vs-Asian
5.453400E-01
Caucasian-vs-AfricanAmerican
4.359800E-01
Caucasian-vs-Asian
8.042200E-02
AfricanAmerican-vs-Asian
1.026840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.324990E-01
Normal-vs-Female
8.114000E-02
Male-vs-Female
7.395000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.635400E-01
Normal-vs-Age(41-60Yrs)
3.204000E-01
Normal-vs-Age(61-80Yrs)
5.554100E-02
Normal-vs-Age(81-100Yrs)
2.768100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.817400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.978200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.837970E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.279200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.748500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.395900E-02
Normal-vs-Daily Drinker
2.385800E-01
Normal-vs-Weekly Drinker
4.845700E-02
Normal-vs-Occasional Drinker
6.602400E-02
Normal-vs-Social Drinker
5.116100E-02
Non Drinker-vs-Daily Drinker
6.258200E-01
Non Drinker-vs-Weekly Drinker
7.805600E-01
Non Drinker-vs-Occasional Drinker
1.137770E-01
Non Drinker-vs-Social Drinker
2.453400E-01
Daily Drinker-vs-Weekly Drinker
8.327400E-01
Daily Drinker-vs-Occasional Drinker
5.119400E-01
Daily Drinker-vs-Social Drinker
6.881600E-01
Weekly Drinker-vs-Occasional Drinker
2.447600E-01
Weekly Drinker-vs-Social Drinker
4.205600E-01
Occasional Drinker-vs-Social Drinker
7.189400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.640000E-02
Normal-vs-Grade 2
5.097500E-03
Normal-vs-Grade 3
4.058200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.447600E-01
Grade 1-vs-Grade 3
8.921600E-01
Grade 1-vs-Grade 4
2.640000E-02
Grade 2-vs-Grade 3
4.371600E-01
Grade 2-vs-Grade 4
5.097500E-03
Grade 3-vs-Grade 4
4.058200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.233800E-02
Normal-vs-NonDiabetic
1.217980E-01
Diabetic-vs-NonDiabetic
7.333600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.016600E-01
Normal-vs-NoPancreatitis
8.083900E-02
Pancreatitis-vs-NoPancreatitis
9.914400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.670000E-02
Normal-vs-N1
1.124560E-01
N0-vs-N1
7.956000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.175600E-01
Normal-vs-TP53-NonMutant
2.509000E-01
TP53-Mutant-vs-TP53-NonMutant
4.253200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
